FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Acetazolamide Injection
Status: Currently in Shortage
»Date first posted: 12/02/2020
»Therapeutic Categories: Cardiovascular; Ophthalmology

Expand all

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 01/13/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg per vial (NDC 0143-9503-01) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing and will be available in the February 2022 timeframe. Product will be made available as it is released. Demand increase for the drug

Mylan Institutional, a Viatris company (Reverified 01/25/2022)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, Lyophilisate in Single Dose Vials 1PK (NDC 67457-853-50) Available Demand increase for the drug

X-GEN Pharmaceuticals, Inc. (Revised 07/08/2021)

Company Contact Information:
866-390-4411

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500mg per vial (NDC 39822-0190-1) Available Check wholesaler inventory Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English